BRIEF-Adaptimmune presents preclinical data from SPEAR T-cell

* Adaptimmune presents preclinical data from a new,

wholly-owned Spear T-cell and a second generation spear T-cell

at the 31st annual meeting of the Society For Immunotherapy for

Cancer (sitc)

Read more